Joakim Wijkstrom Vanda Pharmaceuticals Inc. (VNDA) insider trading activity

Joakim Wijkstrom is SVP, Chief Marketing Officer of Vanda Pharmaceuticals Inc.. Currently has a direct ownership of 239,269 shares of VNDA, which is worth approximately $1.15 Million. The most recent transaction as insider was on Mar 01, 2025, when has been sold 15,520 shares (Common Stock) at a price of $4.76 per share, resulting in proceeds of $73,875. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 239K

84.35% 3M change

84.35% 12M change

Total Value Held $1.15 Million

Joakim Wijkstrom Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Mar 01 2025	SELL Payment of exercise price or tax liability	$73,875 $4.76 p/Share	15,520 Reduced 6.09%	239,269 Common Stock
Feb 18 2025	BUY Grant, award, or other acquisition	-	125,000 Added 32.91%	254,789 Common Stock
Mar 05 2024	SELL Open market or private sale	$38,854 $4.21 p/Share	9,229 Reduced 6.64%	129,789 Common Stock
Mar 04 2024	SELL Open market or private sale	$33,066 $4.41 p/Share	7,498 Reduced 5.12%	139,018 Common Stock
Feb 16 2024	BUY Grant, award, or other acquisition	-	32,700 Added 18.25%	146,516 Common Stock
Aug 21 2023	SELL Open market or private sale	$21,748 $5.84 p/Share	3,724 Reduced 3.17%	113,816 Common Stock
Mar 03 2023	SELL Open market or private sale	$25,994 $6.32 p/Share	4,113 Reduced 3.38%	117,540 Common Stock
Mar 02 2023	SELL Open market or private sale	$48,095 $6.23 p/Share	7,720 Reduced 5.97%	121,653 Common Stock
Feb 16 2023	BUY Grant, award, or other acquisition	-	32,700 Added 20.18%	129,373 Common Stock
Aug 22 2022	SELL Open market or private sale	$37,023 $10.27 p/Share	3,605 Reduced 3.6%	96,673 Common Stock
Mar 02 2022	SELL Open market or private sale	$78,039 $11.19 p/Share	6,974 Reduced 6.5%	100,278 Common Stock
Feb 28 2022	BUY Grant, award, or other acquisition	-	32,700 Added 23.37%	107,252 Common Stock
Aug 20 2021	SELL Open market or private sale	$56,174 $15.39 p/Share	3,650 Reduced 4.67%	74,552 Common Stock
Mar 02 2021	SELL Open market or private sale	$71,734 $18.45 p/Share	3,888 Reduced 4.74%	78,202 Common Stock
Feb 24 2021	BUY Grant, award, or other acquisition	-	25,800 Added 23.91%	82,090 Common Stock

Joakim Wijkstrom

SVP, Chief Marketing Officer

Washington, DC

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells VNDA shares.

Notify only if

Value

Insider Trading

Get notified when an Vanda Pharmaceuticals Inc. insider buys or sells VNDA shares.

Notify only if

Operation

Value

Type

News

Receive news related to Vanda Pharmaceuticals Inc.

Track Activities on VNDA

Account